Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomized clinical trial

被引:0
作者
Joseph Letourneau
Flor Juarez-Hernandez
Kaitlyn Wald
Salustiano Ribeiro
Ange Wang
Charles E. McCulloch
Evelyn Mok-Lin
Milana Dolezal
A. Jo Chien
Marcelle I. Cedars
Mitchell Rosen
机构
[1] University of California,Department of Obstetrics, Gynecology and Reproductive Sciences
[2] San Francisco School of Medicine,Department of Obstetrics and Gynecology
[3] University of Utah School of Medicine,Department of Epidemiology and Biostatistics
[4] Utah Center for Reproductive Medicine,Hematology and Oncology
[5] Seattle Reproductive Medicine,Department of Medicine
[6] University of California,undefined
[7] San Francisco,undefined
[8] California Pacific Medical Center Research Institute,undefined
[9] University of California,undefined
[10] San Francisco School of Medicine,undefined
来源
Journal of Assisted Reproduction and Genetics | 2021年 / 38卷
关键词
Fertility preservation; Breast cancer; Tamoxifen; Letrozole; Ovarian stimulation;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2455 / 2463
页数:8
相关论文
共 186 条
[1]  
Oktay K(2018)Fertility preservation in patients with cancer: ASCO clinical practice guideline update J Clin Oncol 36 1994-2001
[2]  
Harvey BE(2013)Effective method for emergency fertility preservation: random-start controlled ovarian stimulation Fertil Steril 100 1673-1680
[3]  
Partridge AH(2014)Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies Fertil Steril 102 488-495.e3
[4]  
Quinn GP(2010)Laboratory evaluation in oocyte cryopreservation suggests retrieved oocytes are comparable whether frozen for medical indications, deferred reproduction or oocyte donation J Assist Reprod Genet 27 613-617
[5]  
Reinecke J(2020)Fertility preservation before breast cancer treatment appears unlikely to affect disease-free survival at a median follow-up of 43 months after fertility-preservation consultation Cancer. 126 487-495
[6]  
Taylor HS(2003)Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen Hum Reprod 18 90-95
[7]  
Wallace WH(2006)Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy J Clin Endocrinol Metab 91 3885-3890
[8]  
Wang ET(2005)Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation J Clin Oncol 23 4347-4353
[9]  
Loren AW(1993)Administration of an aromatase inhibitor during the late follicular phase of gonadotropin-treated cycles in rhesus monkeys: effects on follicle development, oocyte maturation, and subsequent luteal function The Journal of Clinical Endocrinology& Metabolism 76 988-995
[10]  
Cakmak H(2014)Letrozole versus clomiphene for infertility in the polycystic ovary syndrome N Engl J Med 371 119-129